Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Fund Type: ETF
  • Objective: Health Care
  • Asset Class: Equity
  • Geographic Focus: U.S.

Market Vectors Biotech ETF

+ Add to Watchlist

BBH:US

135.3200 USD 0.0450 0.03%

As of 20:04:04 ET on 05/22/2015.

Snapshot for Market Vectors Biotech ETF (BBH)

Open: 134.9900 High - Low: 135.7800 - 134.9700 Primary Exchange: NYSE Arca
Volume: 88,342 52-Week Range: 89.1400 - 140.7200 Beta vs MVBBHTR: 1.0006

ETF Chart for BBH

No chart data available.
  • BBH:US 135.3200
  • 1D
  • 1M
  • 1Y
135.3650
Interactive BBH Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for BBH

Market Vectors Biotech ETF is an exchange-traded fund incorporated in the USA. The Fund seeks to track the performance of the US Listed Biotech 25 Index.

Inception Date: 2011-12-21 Telephone: 1-212-293-2000
Managers: PETER LIAO / GEORGE CAO
Web Site: www.vaneck.com

Fundamentals for BBH

NAV (on 2015-05-22) 135.3314
Assets (M) (on 2015-05-21) 805.0511
Shares out (M) 5.95
Market Cap (M) 804.68
% Premium -0.01
Average 52-Week % Premium -0.0021
Fund Leveraged N

Dividends for BBH

Dividend Type Income
Dividend Frequency Annual
Last Dividend Net (on 2013-12-23) 0.0030
Dividend Yield (ttm) -%

Performance for BBH

1-Month +0.47% 1-Year +52.18%
3-Month +6.41% 3-Year +43.62%
Year To Date +17.28% 5-Year -
Expense Ratio 0.35

Top Fund Holdings for BBH

Filing Date: 05/21/2015
Name Position Value % of Total
Gilead Sciences Inc 1,081,951 120,334,590 14.938%
Amgen Inc 581,886 95,336,202 11.834%
Celgene Corp 718,898 83,535,948 10.370%
Biogen Inc 158,596 63,620,785 7.897%
Regeneron Pharmaceuticals Inc 90,340 46,615,440 5.787%
BioMarin Pharmaceutical Inc 301,605 38,267,642 4.750%
Illumina Inc 181,453 36,856,733 4.575%
Vertex Pharmaceuticals Inc 281,463 35,196,948 4.369%
Incyte Corp 311,463 33,765,704 4.191%
Alexion Pharmaceuticals Inc 193,047 32,541,933 4.040%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil